Delivery Order SPE2DE24D0013-SPE2D626F9050
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $20,400 firm fixed-price delivery order (Contract No. 4569897059) by the Defense Logistics Agency Medical Supply Chain on October 31, 2025, with an ultimate completion date of November 7, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the supply of molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV)—pathogens critical to military healthcare...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain on November 7, 2025, with an ultimate completion date of November 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and relates to molecular diagnostic testing supplies, specifically reagent cartridges and test kits for detecting COVID-19, influenza, and...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $8,160 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus. The award carries no set-aside designation and represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $1,925 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on October 21, 2025, with an ultimate completion date of October 28, 2025. The contract, designated XPRS-COV2-10, represents a delivery order for diagnostic reagents and test kits—specifically XPRS-COV2-10 cartridges for respiratory pathogen detection on the GeneXpert diagnostic platform....
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F9050Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,270.50 by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 19, 2025. The delivery order, designated XPRSARS-COV2-10, is issued under a firm fixed-price contract structure with no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions, specifically for COVID-19 testing reagents and cartridges compatible with the company's GeneXpert diagnostic platform. The Defense Logistics Agency Medical Supply Chain, operating under the Department of Defense, procures medical supplies and diagnostic testing solutions to support military healthcare operations and broader federal health initiatives. This delivery order aligns with Cepheid's extensive federal contracting portfolio, which includes substantial Indefinite Delivery Contracts with the Department of Veterans Affairs valued at over $39 million through 2030, as well as ongoing procurement relationships with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard. Cepheid's core competency in rapid molecular diagnostic testing for infectious diseases, including COVID-19, influenza, respiratory syncytial virus, and other pathogens, has positioned the company as a critical supplier within the federal healthcare procurement market. The modest ceiling value of this specific delivery order reflects routine replenishment of diagnostic test kits and reagents to support operational testing requirements across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/4/25 |